ReviewLiver cancer2024

Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?

Sang Youn Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.